NCT06035952 is a clinical trial of 3D topographical scan in Scoliosis, sponsored by NSite Medical.

Who is sponsoring NCT06035952?

NCT06035952 is sponsored by NSite Medical.

What drugs are being tested in NCT06035952?

Interventions in NCT06035952: 3D topographical scan.

Is NCT06035952 still recruiting?

NCT06035952 is currently status unknown. Last updated 13 September 2023.

Last reviewed 2023-09-13 · How we verify

NCT06035952

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of 3D Scanning for Adolescent Scoliosis

Status unknown Last updated 13 September 2023

What this trial tests

trial testing 3D topographical scan in Scoliosis in 70 participants. Status unknown.

Timeline

7 August 2023

Primary endpoint
15 October 2023

15 December 2023

Quick facts

Lead sponsor	NSite Medical
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	70
Start date	7 August 2023
Primary completion	15 October 2023
Estimated completion	15 December 2023
Sites	2 locations across United States

Drugs / interventions tested

3D topographical scan

Conditions studied

Scoliosis — all drugs for Scoliosis →

Sponsor

NSite Medical

Who can join

Adults 10 to 18, any sex, with Scoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to validate three-dimensional topographical scanning technology as a tool for evaluation of scoliosis. Through the incorporation of 3D topographical technology in the measurement of deformity, the investigators hope to validate a novel approach to quantify deformity progression and provide an accessible alternative to traditional radiographic workup.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Smartphone-based surface topography app accurately detects clinically significant scoliosis.
Rohde MS, Albarran M, Catanzano AA, Sachs EJ, et al · · 2025 · cited 4× · PMID 40172834 · DOI 10.1007/s43390-025-01062-7

Verify or expand the search:

Other recruiting trials for Scoliosis

Currently open trials in the same condition.

NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
NCT07059663 — Synergic Effects of Schroth Method With and Without Core Stabilization Exercises in Idiopathic Scoliosis Patients · NA · recruiting
NCT06540885 — A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine Surgery · Phase 4 · recruiting
NCT06242821 — Yoga for Back Pain in Adolescent Scoliosis · NA · recruiting
NCT06451562 — Effect of Regional Anesthesia or Intravenous Infusion of Lidocaine on Morphine Use After Scoliosis Repair Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06035952 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NSite Medical
Last refreshed: 13 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing